290 related articles for article (PubMed ID: 19933832)
1. Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response.
Mazumdar S; Mukherjee P; Yazdani SS; Jain SK; Mohmmed A; Chauhan VS
Infect Immun; 2010 Feb; 78(2):872-83. PubMed ID: 19933832
[TBL] [Abstract][Full Text] [Related]
2. Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24.
Gupta PK; Mukherjee P; Dhawan S; Pandey AK; Mazumdar S; Gaur D; Jain SK; Chauhan VS
Clin Vaccine Immunol; 2014 Jun; 21(6):886-97. PubMed ID: 24789797
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants.
Sachdeva S; Mohmmed A; Dasaradhi PV; Crabb BS; Katyal A; Malhotra P; Chauhan VS
Vaccine; 2006 Mar; 24(12):2007-16. PubMed ID: 16377036
[TBL] [Abstract][Full Text] [Related]
5. Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35.
Kalra A; Edula JR; Gupta PK; Pandey AK; Chauhan VS
PLoS One; 2016; 11(10):e0165720. PubMed ID: 27798691
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.
Mamillapalli A; Sunil S; Diwan SS; Sharma SK; Tyagi PK; Adak T; Joshi H; Malhotra P
Malar J; 2007 Jul; 6():95. PubMed ID: 17659072
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
[TBL] [Abstract][Full Text] [Related]
8. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
Mehrizi AA; Zakeri S; Rafati S; Salmanian AH; Djadid ND
Parasite Immunol; 2011 Nov; 33(11):594-608. PubMed ID: 21883290
[TBL] [Abstract][Full Text] [Related]
9. Poly(I:C) adjuvant strongly enhances parasite-inhibitory antibodies and Th1 response against Plasmodium falciparum merozoite surface protein-1 (42-kDa fragment) in BALB/c mice.
Mehrizi AA; Rezvani N; Zakeri S; Gholami A; Babaeekhou L
Med Microbiol Immunol; 2018 Apr; 207(2):151-166. PubMed ID: 29397427
[TBL] [Abstract][Full Text] [Related]
10. Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.
Shi Q; Lynch MM; Romero M; Burns JM
Infect Immun; 2007 Mar; 75(3):1349-58. PubMed ID: 17158895
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.
Nurul AA; Norazmi MN
Parasitol Res; 2011 Apr; 108(4):887-97. PubMed ID: 21057812
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
Woehlbier U; Epp C; Hackett F; Blackman MJ; Bujard H
Malar J; 2010 Mar; 9():77. PubMed ID: 20298576
[TBL] [Abstract][Full Text] [Related]
13. Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
Chitnis CE; Mukherjee P; Mehta S; Yazdani SS; Dhawan S; Shakri AR; Bhardwaj R; Gupta PK; Hans D; Mazumdar S; Singh B; Kumar S; Pandey G; Parulekar V; Imbault N; Shivyogi P; Godbole G; Mohan K; Leroy O; Singh K; Chauhan VS
PLoS One; 2015; 10(4):e0117820. PubMed ID: 25927360
[TBL] [Abstract][Full Text] [Related]
14. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
[TBL] [Abstract][Full Text] [Related]
15. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
16. Expression of an immunologically reactive merozoite surface protein (MSP-1(42)) in E. coli.
Leung WH; Meng ZQ; Hui G; Ho WK
Biochim Biophys Acta; 2004 Nov; 1675(1-3):62-70. PubMed ID: 15535968
[TBL] [Abstract][Full Text] [Related]
17. A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response.
Cowan GJ; Creasey AM; Dhanasarnsombut K; Thomas AW; Remarque EJ; Cavanagh DR
PLoS One; 2011; 6(10):e26616. PubMed ID: 22073118
[TBL] [Abstract][Full Text] [Related]
18. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.
Guevara Patiño JA; Holder AA; McBride JS; Blackman MJ
J Exp Med; 1997 Nov; 186(10):1689-99. PubMed ID: 9362529
[TBL] [Abstract][Full Text] [Related]
19. Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum.
Arnot DE; Cavanagh DR; Remarque EJ; Creasey AM; Sowa MP; Morgan WD; Holder AA; Longacre S; Thomas AW
Clin Vaccine Immunol; 2008 Sep; 15(9):1345-55. PubMed ID: 18550731
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
Cavanagh DR; Kocken CH; White JH; Cowan GJ; Samuel K; Dubbeld MA; Voorberg-van der Wel A; Thomas AW; McBride JS; Arnot DE
PLoS One; 2014; 9(1):e83704. PubMed ID: 24421900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]